Efloxate

{{Short description|Chemical compound}}

{{more citations needed|date=February 2022}}

{{Drugbox

| Watchedfields = changed

| verifiedrevid = 444355205

| IUPAC_name = ethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate

| image = Efloxate.png

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 119-41-5

| ATC_prefix = C01

| ATC_suffix = DX13

| PubChem = 8395

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = CZU6V3902K

| ChemSpiderID = 8089

| ChEMBL = 1349073

| C=19 | H=16 | O=5

| smiles = CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3

| StdInChI = 1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3

| StdInChIKey = ZVXBAHLOGZCFTP-UHFFFAOYSA-N

}}

Efloxate is a vasodilator.{{cite journal | vauthors = Tomasi AM, Masoni A | title = [Clinical research on the therapeutic efficacy and tolerance of long-acting efloxate in angina pectoris] | language = Italian | journal = La Clinica Terapeutica | volume = 82 | issue = 3 | pages = 227–41 | date = August 1977 | pmid = 334448 | doi = | url = }}